BHCM
OGN icon

Boulder Hill Capital Management’s Organon & Co OGN Stock Holding History

Boulder Hill Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,200
Closed -$262K – 196
2022
Q3 		$262K Sell
11,200
-12,900
-54% -$389K 0.2% 117
2022
Q2 		$813K Buy
+24,100
New +$844K 0.93% 45

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boulder Hill Capital Management's OGN Position: Q4 2022 in Review

Boulder Hill Capital Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 11,200 shares — an estimated $262K sold.

Boulder Hill Capital Management first reported a position in OGN in Q2 2022 and held it in 2 quarters. The position peaked at $813K in Q2 2022. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Boulder Hill Capital Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Boulder Hill Capital Management sold 11,200 Organon & Co shares in Q4 2022, an estimated $262K.
  • Boulder Hill Capital Management first reported a position in Organon & Co in Q2 2022 and held it in 2 quarters.
  • Boulder Hill Capital Management's Organon & Co position peaked at $813K in Q2 2022.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Boulder Hill Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.